Aprea Therapeutics, Inc. (APRE)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-16 | Grissinger Michael | director | A | 3,135 | 0 | $0 |
| 2026-06-16 | Gruia Gabriela | director | A | 3,135 | 0 | $0 |
| 2026-06-16 | Peters Richard | director | A | 3,135 | 0 | $0 |
| 2026-06-16 | HENNEMAN JOHN B III | director | A | 3,135 | 0 | $0 |
| 2026-06-16 | BIZZARI JEAN-PIERRE | director | A | 3,135 | 0 | $0 |
| 2026-06-16 | Duey Marc | director | A | 3,135 | 0 | $0 |
| 2026-06-16 | Pamukcu Rifat | director | A | 3,135 | 0 | $0 |
| 2026-06-16 | Seizinger Bernd R. | director | A | 3,135 | 0 | $0 |
| 2026-03-12 | Gilad Oren | director | A | 20,175 | 0 | $0 |
| 2026-03-12 | Hamill John P. | officer | A | 10,095 | 0 | $0 |
| 2026-01-30 | Gilad Oren | director | P | 28,100 | 0.89 | $25,009 |
| 2026-01-30 | Hamill John P. | officer | P | 5,700 | 0.89 | $5,073 |
| 2025-12-10 | Duey Marc | director | P | 21,459 | 1.17 | $25,107 |
| 2025-12-10 | Hamill John P. | officer | P | 5,000 | 1.17 | $5,850 |
| 2025-06-05 | Seizinger Bernd R. | director | A | 1,045 | 0 | $0 |
| 2025-06-05 | Peters Richard | director | A | 1,045 | 0 | $0 |
| 2025-06-05 | Pamukcu Rifat | director | A | 1,045 | 0 | $0 |
| 2025-06-05 | HENNEMAN JOHN B III | director | A | 1,045 | 0 | $0 |
| 2025-06-05 | Gruia Gabriela | director | A | 1,045 | 0 | $0 |
| 2025-06-05 | Grissinger Michael | director | A | 1,045 | 0 | $0 |
| 2025-06-05 | Duey Marc | director | A | 1,045 | 0 | $0 |
| 2025-06-05 | BIZZARI JEAN-PIERRE | director | A | 1,045 | 0 | $0 |
| 2025-04-03 | Gilad Oren | director | P | 3,003 | 1.87 | $5,616 |
| 2025-04-03 | Gilad Oren | director | P | 2,497 | 1.8 | $4,495 |
| 2025-03-27 | Gilad Oren | director | A | 6,725 | 0 | $0 |
| 2025-03-27 | Hamill John P. | officer | A | 3,365 | 0 | $0 |
| 2024-10-23 | Gilad Oren | director | P | 500 | 3.92 | $1,960 |
| 2024-10-18 | Duey Marc | director | S | 6,462 | 4.58 | $29,596 |
| 2024-10-16 | Duey Marc | director | P | 30,000 | 4.39 | $131,700 |
| 2024-10-15 | Gilad Oren | director | P | 250 | 2.9 | $725 |
| 2024-10-14 | Gilad Oren | director | P | 1,000 | 2.59 | $2,590 |
| 2024-10-14 | Duey Marc | director | P | 190 | 2.58 | $490 |
| 2024-10-11 | Seizinger Bernd R. | director | P | 10,000 | 2.68 | $26,800 |
| 2024-10-11 | Hamill John P. | officer | P | 50 | 2.46 | $123 |
| 2024-10-10 | Hamill John P. | officer | P | 450 | 2.61 | $1,175 |
| 2024-10-10 | Gilad Oren | director | P | 150 | 2.54 | $381 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.